Thursday, Mar 14, 2024 · SEC filings
What the smart money revealed on Mar 14
650 insider filings came in. We hid 62 planned (10b5-1) sellers and 376 people whose filings were routine, like grants and tax withholding.
4 insiders at Aprea Therapeutics (APRE) bought $122K of stock
Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.
KKR FS Income Trust Select President and CEO Michael Forman bought $2.86M
114,561 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 4 checked quarters beat the typical stock 6 months later.
Geo Group (GEO) Executive Chairman George Zoley bought $624K
50,000 shares on the open market. Not a grant or an option exercise.
Opko Health (OPK) CEO and Chairman Frost Phillip Md Et Al bought $445K
500,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 9 checked quarters beat the typical stock 6 months later.
Crocs (CROX) Director John Replogle bought $250K
1,972 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 7 checked quarters beat the typical stock 6 months later.
Antero Resources (AR) Director W. Howard Keenan Jr. sold $26.2M
Not marked as a planned 10b5-1 sale. Sold 25% of the shares they held directly. Still holds 3M shares.
Walmart (WMT) Director S. Robson Walton sold $21M
Not marked as a planned 10b5-1 sale. Sold 1% of the shares they held directly. Still holds 652.04M shares.
BeiGene (ONC) CEO John Oyler sold $8.37M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 48 more real buys
Show 127 more real sales
13F season
Holdings as of Dec 31, 2023 were due Feb 14
49 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Mar 8–14
Open-market buys by officers and directors, filed in the 7 days up to Mar 14.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.